-
361
-
362
Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors
Published 2025-01-01Subjects: Get full text
Article -
363
-
364
Development of highly bioactive long-acting recombinant porcine FSH for batch production management of sows
Published 2025-02-01Subjects: Get full text
Article -
365
Effects of levothyroxine therapy on bone and mineral metabolism in hypothyroidism: a systematic review and meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
366
Effect of Radiation, Organic Solvents and Vibration Occupational Exposure on the Thyroid Disease: Results from Project ELEFANT
Published 2021-06-01Subjects: Get full text
Article -
367
Co-occurrence of a Mullerian anomaly and Kallmann syndrome: A case report
Published 2025-03-01Subjects: Get full text
Article -
368
Middle Ear Metastases as the Initial Presentation of Breast Cancer Progression
Published 2023-07-01Subjects: Get full text
Article -
369
X-linked ubiquitin-specific peptidase 11 (USP11) increases susceptibility to Cushing’s disease in women
Published 2025-02-01Subjects: Get full text
Article -
370
-
371
Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
Published 2025-03-01Subjects: Get full text
Article -
372
-
373
Causal relationship between inflammatory bowel disease and sex: a Mendelian randomization study
Published 2025-01-01Subjects: “…sex hormone…”
Get full text
Article -
374
Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
Published 2024-09-01Subjects: Get full text
Article -
375
Comparative analysis of the ftness of Drosophila virilis lines contrasting in response to stress
Published 2019-01-01Subjects: Get full text
Article -
376
The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer
Published 2024-01-01“…Endocrine therapy combined with cyclin-dependent kinase (CDK) 4/6 inhibitors (CDK4/6i) is the preferred treatment for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) metastatic breast cancer (MBC). …”
Get full text
Article -
377
Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
Published 2013-01-01“…We aimed to describe the functional changes of Sertoli cells, based on the measurement of serum anti-Müllerian hormone (AMH) and inhibin B during treatment with GnRHa and after its withdrawal in boys with central precocious puberty. …”
Get full text
Article -
378
Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women
Published 2025-01-01“…Background/Objectives: This study aims to assess the effects of combined hormonal contraceptives (CHCs) on bone metabolism markers. …”
Get full text
Article -
379
Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
Published 2023-04-01“…All participants underwent a detailed clinical evaluation and biochemical investigations, including high-sensitivity C-reactive protein, serum adiponectin, luteinising hormone, follicle-stimulating hormone, total testosterone and serum anti-Mullerian hormone. …”
Get full text
Article -
380